Annual report
2689.TEDINET S100P7E8
Period2021-07-01 → 2022-06-30
Filed2022-09-22
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥108.0bn | 2021-07-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥102.1bn | 2020-07-01 → 2021-06-30 | Cons. | Net sales |
| Revenue | ¥97.9bn | 2019-07-01 → 2020-06-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥98.0bn | 2018-07-01 → 2019-06-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥97.9bn | 2017-07-01 → 2018-06-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥2.1bn | 2021-07-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥1.5bn | 2020-07-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥2.1bn | 2021-07-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.5bn | 2020-07-01 → 2021-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥906m | 2019-07-01 → 2020-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.3bn | 2018-07-01 → 2019-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.2bn | 2017-07-01 → 2018-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.1bn | 2021-07-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.5bn | 2020-07-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.5bn | 2021-07-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥989m | 2020-07-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥326m | 2019-07-01 → 2020-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥776m | 2018-07-01 → 2019-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.1bn | 2017-07-01 → 2018-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.5bn | 2021-07-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥989m | 2020-07-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥40.0bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥36.6bn | at 2021-06-30 | Cons. | Assets |
| Total assets | ¥33.7bn | at 2020-06-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥33.8bn | at 2019-06-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥33.4bn | at 2018-06-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥30.9bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥28.4bn | at 2021-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥9.1bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥8.1bn | at 2021-06-30 | Cons. | Net assets |
| Net assets / equity | ¥7.3bn | at 2020-06-30d | Cons. | Net assets |
| Net assets / equity | ¥6.8bn | at 2019-06-30d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥6.4bn | at 2018-06-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.2bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.2bn | at 2021-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.1bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.1bn | at 2021-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2020-06-30d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2019-06-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.4bn | at 2018-06-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥2.4bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.1bn | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥863m | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥137m | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥314m | 2017-07-01 → 2018-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥212m | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥630m | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥496m | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥362m | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥269m | 2017-07-01 → 2018-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥1.2bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.3bn | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥440m | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥63m | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥228m | 2017-07-01 → 2018-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥252.8 | 2021-07-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥162.66 | 2020-07-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥56.76 | 2019-07-01 → 2020-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥138.24 | 2018-07-01 → 2019-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥187.86 | 2017-07-01 → 2018-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,513.91 | at 2022-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,336.91 | at 2021-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,197.17 | at 2020-06-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,191.62 | at 2019-06-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,121.32 | at 2018-06-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 22.8% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.2% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 21.6% | at 2020-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 19.8% | at 2019-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 18.8% | at 2018-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 17.8% | 2021-07-01 → 2022-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.8% | 2020-07-01 → 2021-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.7% | 2019-07-01 → 2020-06-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.0% | 2018-07-01 → 2019-06-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 18.2% | 2017-07-01 → 2018-06-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,289 | at 2022-06-30 | Cons. | Number of employees |
| Employees | 1,261 | at 2021-06-30 | Cons. | Number of employees |
| Employees | 1,222 | at 2020-06-30d | Cons. | Number of employees |
| Employees | 1,189 | at 2019-06-30d | Cons. | Number of employees |
| Employees | 1,163 | at 2018-06-30d | Cons. | Number of employees |
| Revenue | ¥2.2bn | 2021-07-01 → 2022-06-30 | Standalone | Net sales |
| Revenue | ¥1.7bn | 2020-07-01 → 2021-06-30 | Standalone | Net sales |
| Revenue | ¥1.6bn | 2019-07-01 → 2020-06-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.6bn | 2018-07-01 → 2019-06-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.2bn | 2017-07-01 → 2018-06-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.0bn | 2021-07-01 → 2022-06-30 | Standalone | Operating income |
| Operating income | ¥484m | 2020-07-01 → 2021-06-30 | Standalone | Operating income |
| Ordinary income | ¥1.0bn | 2021-07-01 → 2022-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥477m | 2020-07-01 → 2021-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥239m | 2019-07-01 → 2020-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥447m | 2018-07-01 → 2019-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥953m | 2017-07-01 → 2018-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥993m | 2021-07-01 → 2022-06-30 | Standalone | Income before income taxes |
| Profit before tax | ¥447m | 2020-07-01 → 2021-06-30 | Standalone | Income before income taxes |
| Net income | ¥999m | 2021-07-01 → 2022-06-30 | Standalone | Profit loss |
| Net income | ¥384m | 2020-07-01 → 2021-06-30 | Standalone | Profit loss |
| Net income | −¥228m | 2019-07-01 → 2020-06-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥260m | 2018-07-01 → 2019-06-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1000m | 2017-07-01 → 2018-06-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥8.9bn | at 2022-06-30 | Standalone | Assets |
| Total assets | ¥7.8bn | at 2021-06-30 | Standalone | Assets |
| Total assets | ¥8.8bn | at 2020-06-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥8.1bn | at 2019-06-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥8.2bn | at 2018-06-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥4.3bn | at 2022-06-30 | Standalone | Liabilities |
| Total liabilities | ¥3.7bn | at 2021-06-30 | Standalone | Liabilities |
| Net assets / equity | ¥4.7bn | at 2022-06-30 | Standalone | Net assets |
| Net assets / equity | ¥4.1bn | at 2021-06-30 | Standalone | Net assets |
| Net assets / equity | ¥4.0bn | at 2020-06-30d | Standalone | Net assets |
| Net assets / equity | ¥4.0bn | at 2019-06-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥4.0bn | at 2018-06-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.9bn | at 2022-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥764m | at 2021-06-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥164.46 | 2021-07-01 → 2022-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥63.17 | 2020-07-01 → 2021-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-39.73 | 2019-07-01 → 2020-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.31 | 2018-07-01 → 2019-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥178.19 | 2017-07-01 → 2018-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥60 | 2021-07-01 → 2022-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2020-07-01 → 2021-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥45 | 2019-07-01 → 2020-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2018-07-01 → 2019-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2017-07-01 → 2018-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥775.62 | at 2022-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥673.94 | at 2021-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥656.64 | at 2020-06-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥710.19 | at 2019-06-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥717.98 | at 2018-06-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 52.1% | at 2022-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.3% | at 2021-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.5% | at 2020-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.5% | at 2019-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.1% | at 2018-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 22.8% | 2021-07-01 → 2022-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.5% | 2020-07-01 → 2021-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -5.7% | 2019-07-01 → 2020-06-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.5% | 2018-07-01 → 2019-06-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 27.7% | 2017-07-01 → 2018-06-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 6,250,000 | at 2022-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,250,000 | at 2021-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,250,000 | at 2020-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,250,000 | at 2019-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,250,000 | at 2018-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 41 | at 2022-06-30 | Standalone | Number of employees |
| Employees | 39 | at 2021-06-30 | Standalone | Number of employees |
| Employees | 37 | at 2020-06-30d | Standalone | Number of employees |
| Employees | 34 | at 2019-06-30d | Standalone | Number of employees |
| Employees | 33 | at 2018-06-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 71
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2021-07-01 → 2022-06-30 | ¥91m |
| Reconciling Itemsreconciling | depreciation | 2021-07-01 → 2022-06-30 | ¥32m |
| Reconciling Itemsreconciling | revenue | 2021-07-01 → 2022-06-30 | −¥1.4bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-07-01 → 2022-06-30 | −¥1.4bn |
| Reconciling Itemsreconciling | segment assets | at 2022-06-30 | −¥4.4bn |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2022-06-30 | −¥158m |
| Care Nursing Goodsreportable segment | capex | 2021-07-01 → 2022-06-30 | ¥1m |
| Care Nursing Goodsreportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥4m |
| Care Nursing Goodsreportable segment | employees | at 2022-06-30 | 135 pure |
| Care Nursing Goodsreportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥2.4bn |
| Care Nursing Goodsreportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥2.4bn |
| Care Nursing Goodsreportable segment | revenue intersegment | 2021-07-01 → 2022-06-30 | ¥559,000 |
| Care Nursing Goodsreportable segment | segment assets | at 2022-06-30 | ¥983m |
| Care Nursing Goodsreportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥171m |
| Medical Equipmentreportable segment | capex | 2021-07-01 → 2022-06-30 | ¥374m |
| Medical Equipmentreportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥344m |
| Medical Equipmentreportable segment | employees | at 2022-06-30 | 938 pure |
| Medical Equipmentreportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥102.2bn |
| Medical Equipmentreportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥101.0bn |
| Medical Equipmentreportable segment | revenue intersegment | 2021-07-01 → 2022-06-30 | ¥1.2bn |
| Medical Equipmentreportable segment | segment assets | at 2022-06-30 | ¥37.8bn |
| Medical Equipmentreportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥1.9bn |
| SPDreportable segment | capex | 2021-07-01 → 2022-06-30 | ¥12m |
| SPDreportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥19m |
| SPDreportable segment | employees | at 2022-06-30 | 175 pure |
| SPDreportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥4.7bn |
| SPDreportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥4.6bn |
| SPDreportable segment | revenue intersegment | 2021-07-01 → 2022-06-30 | ¥154m |
| SPDreportable segment | segment assets | at 2022-06-30 | ¥5.5bn |
| SPDreportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥171m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-07-01 → 2022-06-30 | ¥387m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-07-01 → 2022-06-30 | ¥367m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-07-01 → 2022-06-30 | ¥109.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-07-01 → 2022-06-30 | ¥108.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-07-01 → 2022-06-30 | ¥1.4bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-06-30 | ¥44.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-07-01 → 2022-06-30 | ¥2.2bn |
| Reconciling Itemsreconciling | capex | 2020-07-01 → 2021-06-30 | ¥226m |
| Reconciling Itemsreconciling | depreciation | 2020-07-01 → 2021-06-30 | ¥46m |
| Reconciling Itemsreconciling | revenue | 2020-07-01 → 2021-06-30 | −¥1.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2020-07-01 → 2021-06-30 | −¥1.3bn |
| Reconciling Itemsreconciling | segment assets | at 2021-06-30 | −¥3.4bn |
| Reconciling Itemsreconciling | segment profit | 2020-07-01 → 2021-06-30 | −¥150m |
| Care Nursing Goodsreportable segment | capex | 2020-07-01 → 2021-06-30 | ¥14m |
| Care Nursing Goodsreportable segment | depreciation | 2020-07-01 → 2021-06-30 | ¥4m |
| Care Nursing Goodsreportable segment | revenue | 2020-07-01 → 2021-06-30 | ¥2.3bn |
| Care Nursing Goodsreportable segment | revenue external | 2020-07-01 → 2021-06-30 | ¥2.3bn |
| Care Nursing Goodsreportable segment | revenue intersegment | 2020-07-01 → 2021-06-30 | ¥580,000 |
| Care Nursing Goodsreportable segment | segment assets | at 2021-06-30 | ¥899m |
| Care Nursing Goodsreportable segment | segment profit | 2020-07-01 → 2021-06-30 | ¥145m |
| Medical Equipmentreportable segment | capex | 2020-07-01 → 2021-06-30 | ¥386m |
| Medical Equipmentreportable segment | depreciation | 2020-07-01 → 2021-06-30 | ¥331m |
| Medical Equipmentreportable segment | revenue | 2020-07-01 → 2021-06-30 | ¥96.5bn |
| Medical Equipmentreportable segment | revenue external | 2020-07-01 → 2021-06-30 | ¥95.4bn |
| Medical Equipmentreportable segment | revenue intersegment | 2020-07-01 → 2021-06-30 | ¥1.2bn |
| Medical Equipmentreportable segment | segment assets | at 2021-06-30 | ¥33.8bn |
| Medical Equipmentreportable segment | segment profit | 2020-07-01 → 2021-06-30 | ¥1.4bn |
| SPDreportable segment | capex | 2020-07-01 → 2021-06-30 | ¥45m |
| SPDreportable segment | depreciation | 2020-07-01 → 2021-06-30 | ¥15m |
| SPDreportable segment | revenue | 2020-07-01 → 2021-06-30 | ¥4.5bn |
| SPDreportable segment | revenue external | 2020-07-01 → 2021-06-30 | ¥4.4bn |
| SPDreportable segment | revenue intersegment | 2020-07-01 → 2021-06-30 | ¥124m |
| SPDreportable segment | segment assets | at 2021-06-30 | ¥5.2bn |
| SPDreportable segment | segment profit | 2020-07-01 → 2021-06-30 | ¥134m |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-07-01 → 2021-06-30 | ¥444m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-07-01 → 2021-06-30 | ¥350m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-07-01 → 2021-06-30 | ¥103.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-07-01 → 2021-06-30 | ¥102.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-07-01 → 2021-06-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-06-30 | ¥39.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-07-01 → 2021-06-30 | ¥1.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,447
| Item | Context | Value | Unit |
|---|---|---|---|
| Other net inv cf | CurrentYearDuration | 10000 | JPY |
| Net cash provided by used in investment activities | Prior1YearDuration | -630379000 | JPY |
| Net cash provided by used in investment activities | CurrentYearDuration | -211806000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YearDuration | -1500000000 | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYearDuration | -300000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YearDuration | -320000000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYearDuration | -220000000 | JPY |
| Repayments of lease obligations fin cf | Prior1YearDuration | -169190000 | JPY |
| Repayments of lease obligations fin cf | CurrentYearDuration | -174098000 | JPY |
| Proceeds from sale and leaseback fin cf | Prior1YearDuration | 5984000 | JPY |
| Proceeds from sale and leaseback fin cf | CurrentYearDuration | 1738000 | JPY |
| Purchase of treasury stock fin cf | Prior1YearDuration | -109000 | JPY |
| Purchase of treasury stock fin cf | CurrentYearDuration | -135748000 | JPY |
| Payments from changes in ownership interests in subsidiaries that do not result in change in scope of consolidation fin cf | Prior1YearDuration | － | JPY |
| Payments from changes in ownership interests in subsidiaries that do not result in change in scope of consolidation fin cf | CurrentYearDuration | -31250000 | JPY |
| Cash dividends paid fin cf | Prior1YearDuration | -278680000 | JPY |
| Cash dividends paid fin cf | CurrentYearDuration | -310547000 | JPY |
| Other net fin cf | Prior1YearDuration | -544000 | JPY |
| Other net fin cf | CurrentYearDuration | － | JPY |
| Net cash provided by used in financing activities | Prior1YearDuration | -2262540000 | JPY |
| Net cash provided by used in financing activities | CurrentYearDuration | -1169906000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YearDuration | － | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYearDuration | － | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YearDuration | 233387000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYearDuration | 1038929000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 1877288000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 2110675000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 2110675000 | JPY |
| Cash and cash equivalents | CurrentYearInstant | 3149605000 | JPY |
| Number of consolidated subsidiaries | CurrentYearInstant | 7 | |
| Write downs of inventories | Prior1YearDuration | -414000 | JPY |
| Write downs of inventories | CurrentYearDuration | -12144000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E02928-000MedicalEquipmentReportableSegmentsMember | 95392354000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E02928-000SPDReportableSegmentsMember | 4364446000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E02928-000CareNursingGoodsReportableSegmentsMember | 2315233000 | JPY |
| Revenues from external customers | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 102072033000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YearDuration | 102072033000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E02928-000MedicalEquipmentReportableSegmentsMember | 1152690000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E02928-000SPDReportableSegmentsMember | 124402000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E02928-000CareNursingGoodsReportableSegmentsMember | 580000 | JPY |
| Transactions with other segments | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 1277673000 | JPY |
| Transactions with other segments | Prior1YearDuration_ReconcilingItemsMember | -1277673000 | JPY |
| Transactions with other segments | Prior1YearDuration | － | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E02928-000MedicalEquipmentReportableSegmentsMember | 96545044000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E02928-000SPDReportableSegmentsMember | 4488848000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E02928-000CareNursingGoodsReportableSegmentsMember | 2315813000 | JPY |
| Net sales | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 103349706000 | JPY |
| Net sales | Prior1YearDuration_ReconcilingItemsMember | -1277673000 | JPY |
| Net sales | Prior1YearDuration | 102072033000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |